Tristel PLC NZ ENT study shows Tristel Wipes System benefits (6479W)
November 11 2014 - 2:01AM
UK Regulatory
TIDMTSTL
RNS Number : 6479W
Tristel PLC
11 November 2014
TRISTEL plc
("Tristel", "the Company" or "the Group")
New Zealand ENT study shows Tristel Wipes System benefits
Tristel plc (AIM: TSTL), the manufacturer of infection
prevention, contamination control and hygiene products, announces
that a New Zealand study has demonstrated the productivity and
costs benefits brought about through the introduction of the
Tristel Wipes System for use on nasendoscopes in Ear Nose and
Throat out-patient clinics, compared to a centralized
decontamination process.
The study was undertaken by Counties Manukau Health Board, in
the ENT out-patients clinic, and focussed on the benefits of
adopting the Tristel Wipes System for the high-level disinfection
of nasendoscopes. The results of the study were presented at the
3(rd) Asia Pacific Healthcare Forum in September 2014.
The ENT out-patient service at Counties Manukau Hospital is one
of New Zealand's busiest with an average of 94 flexible
nasendoscopies being carried out each week during the twelve month
study. The hospital turned to the Wipes System in an attempt to
resolve various problems that the incumbent decontamination process
- a Steris System 1 automated endoscope reprocessor located in a
Central Sterilisation Service Department ('CSSD') - could not. The
problems were:-
-- The incumbent process involved such a slow turnaround time
for the endoscopes that it caused increased frustrations amongst
the clinicians as they did not have nasendoscopes available when
needed to examine patients;
-- There was a flow-on effect of stress for all departmental staff;
-- The endoscope reprocessor and the transportation of the
scopes around the hospital increased damage to them putting
pressure on the hospital's scope fleet;
The Study documented the effects of the change to the Wipes
System which were found to be:-
-- An immediate, noticeable decrease in clinician frustration;
-- An immediate increased turnaround time in scope reprocessing and scope availability;
-- Decreased appointment time/ waiting time for patients due to scopes being readily available;
-- Cost savings from the scopes being decontaminated in the ENT
out-patient clinic as opposed to being transported to and from the
CSSD.
The annual cost savings of the Wipes System compared to Steris
System 1, which included the reduction in staff time involved in
scope reprocessing, were calculated at NZ101,950 (approximately
UKGBP50,000). The concluding observations of the ENT department
staff were that 72% strongly agreed and 28% agreed that the
implementation of the Wipes System had been a success.
More details of the study are available here:
http://www.rns-pdf.londonstockexchange.com/rns/6479W_1-2014-11-10.pdf
Paul Swinney, Chief Executive of Tristel plc, said: "This is the
latest published study to confirm the productivity and cost
benefits of the Tristel Wipes System. We enable endoscopes to be
decontaminated within the out-patient clinic, avoiding the risks
and time delays of transporting instruments around the hospital. At
Counties Manukau, before Tristel was adopted, it was often not
possible for the ENT clinician to complete a full examination of
the patient because a decontaminated scope was not available. This
would require the patient either to return for another visit or to
endure a long wait.
"The benefits of the Wipes System are now widely documented and
this has become a major factor in their global success. During our
last financial year 2.2 million decontamination procedures were
undertaken using the Wipes System in 41 countries."
For further information:
Tristel plc Tel: 01638 721 500
Paul Swinney, Chief Executive
Liz Dixon, Finance Director
Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
FinnCap Tel: 020 7600 1658
Geoff Nash / Charlotte Stranner (Corporate
Finance)
Stephen Norcross (Corporate Broking)
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAEAXFEFEALFFF
Tristel (LSE:TSTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tristel (LSE:TSTL)
Historical Stock Chart
From Apr 2023 to Apr 2024